TEXTILES.ORG
Secant Medical has announced the availability of two diverse products that can advance the research and product development needs of medical device OEMs. The company is launching an off-the-shelf, low-profile fabric for next-generation endovascular aneurysm repair (EVAR) or heart valve component design, and Regenerez™, a research-grade resin for tissue engineering applications.
“Available in eight different varieties, our woven low-profile fabrics offer clients an economical entrance into the market,” says Dan Treusch, business manager at Secant Medical. “Accessible through quick ship delivery, this product can help streamline our client’s development process.” Biocompatibility, low-permeability, high burst strength, and compaction for MIS delivery are features and benefits of the low-profile woven fabric.
“Regenerez, our research-grade biomaterial, is a bioresorbable elastomer platform for regenerative medicine. It has tunable mechanical properties and enables healing without creating a harmful immune response,” said Dr. Josh Simon, business development manager at Secant Medical. “The material’s flexibility and inherent elastomeric properties offer limitless possibilities for tissue engineering in a variety of in vivo applications.”
Secant Medical provides advanced biomaterials and biomedical textile structures to the medical device industry.